Skip to main content
MRCY
NASDAQ Manufacturing

Mercury Systems Posts Record Q4 Bookings of $660M and Backlog Above $1.9B; Raises FY27 Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Aerospace & Defense Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$101.64
Mkt Cap
$6.305B
52W Low
$62.78
52W High
$128.45
52W Position info
62% above low
Off High info
21% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

MRCY sits 62% above its 52-week low of $62.78 on elevated volume (2.4× avg).

Summary

Mercury Systems reported record Q4 FY26 bookings of $660M, record backlog over $1.9B, and raised FY27 guidance to ~$1.1B revenue and ~$200M adjusted EBITDA.


Key Events · Earnings and Guidance · MRCY

  • Record Q4 Bookings and Backlog

    Q4 FY26 bookings of $660 million grew 93.1% year-over-year, yielding a 2.28 book-to-bill. Total backlog reached over $1.9 billion, up 38.4% year-over-year, with $1.0 billion expected to convert to revenue within 12 months.

  • Record Revenue and Margin Expansion

    Q4 FY26 revenue of $289.8 million grew 6.1% year-over-year. Adjusted EBITDA was $48.5 million with a 16.7% margin, up 217 basis points for the full year to 15.3%.

  • FY27 Guidance Raised

    Management expects FY27 revenue approaching $1.1 billion (high single-digit to low double-digit growth) and adjusted EBITDA approaching $200 million, reflecting nearly 30% year-over-year growth. Adjusted EBITDA margin is expected in the high-teens.

  • Free Cash Flow Investment Phase

    FY27 free cash flow conversion is expected to approach 35%, below the 50% target, due to planned inventory, automation, and factory optimization investments. Q1 FY27 is expected to be a larger outflow than normal.


Analysis · MRCY · Manufacturing

A blowout fourth quarter saw Mercury Systems deliver record bookings of $660 million, nearly double its previous high, driving a 2.28 book-to-bill and pushing backlog past $1.9 billion. Revenue reached a record $290 million, and adjusted EBITDA margin expanded to 16.7%. Management raised its FY27 outlook to revenue approaching $1.1 billion and adjusted EBITDA approaching $200 million, citing strong defense demand and multi-year customer commitments. The results validate the company's turnaround and position it for accelerating organic growth, though free cash flow conversion is expected to dip to 35% in FY27 due to inventory investments.

At the time of this filing, MRCY was trading at $101.64 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $62.78 to $128.45. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MRCY - Latest Insights

MRCY
Aug 03, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
MRCY
May 28, 2026, 5:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
MRCY
May 05, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
MRCY
May 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
MRCY
Mar 12, 2026, 5:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7